Local drug makers brace for severe damage

Published: 2003-04-29 06:59:00

Updated: 2003-04-29 06:59:00

Korea's drug makers are bracing for a prolonged downdraft in the domestic pharmaceutical market following the government's ex post facto drug pricing inspection on 4,300 items from 190 medical institutions, which have been conducted by the Health Insurance Review Agency in a period ranging from A...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK